Robust delivery of RIG‐I agonists using extracellular vesicles for anti‐cancer immunotherapy
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Extracellular Vesicles"
DOI: 10.1002/jev2.12187
Abstract: Abstract The RIG‐I pathway can be activated by RNA containing 5′ triphosphate, leading to type I interferon release and immune activation. Hence, RIG‐I agonists have been used to induce immune responses against cancer as potential… read more here.
Keywords: extracellular vesicles; rig agonists; immunotherapy; delivery ... See more keywords